Exegenesis Bio
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU) (NCT06817343) | Exegenesis Bio | 2024-09-10 |
| A Study of EXG102-031 in Patients With wAMD (Everest) (NCT05903794) | Exegenesis Bio | 2023-07-24 |
Track Exegenesis Bio automatically
Every clearance here is in the API, with alerts when new ones post.